Trials / Completed
CompletedNCT02491788
Examination of the Effectiveness of Suvorexant in Improving Daytime Sleep in Shift Workers
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 19 (actual)
- Sponsor
- VA Palo Alto Health Care System · Federal
- Sex
- All
- Age
- 20 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to test the hypothesis that ingestion of the wake-inhibiting drug suvorexant 30 minutes prior to daytime sleep initiation in individuals working overnight shifts will significantly improve both objective (total sleep time, sleep efficiency, wake after sleep onset) and subjective (sleep quality) measures of daytime sleep.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Suvorexant | |
| DRUG | Placebo |
Timeline
- Start date
- 2016-02-01
- Primary completion
- 2019-08-01
- Completion
- 2019-08-01
- First posted
- 2015-07-08
- Last updated
- 2020-07-01
- Results posted
- 2020-06-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02491788. Inclusion in this directory is not an endorsement.